Article(id=1330184288881979689, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184264366272602, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.06.004, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1668096000000, receivedDateStr=2022-11-11, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795070248098, onlineDateStr=2026-11-19, pubDate=1686326400000, pubDateStr=2023-06-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795070248098, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795070248098, creator=13701087609, updateTime=1795070248098, updator=13701087609, issue=Issue{id=1330184264366272602, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='6', pageStart='813', pageEnd='981', issueExtLink='null', onlineDate='null', pubDate='1686326400000', pubDateStr='2023-06-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795070242253, creator='13701087609', updateTime=1795080494688, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330227266719691144, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184264366272602, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330227266719691145, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184264366272602, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=859, endPage=866, ext={EN=ArticleExt(id=1330184289121055018, articleId=1330184288881979689, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Advances in Purification Process of IgG-like Bispecific Antibodies, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

IgG-like bispecific antibodies are artificially constructed functional antibodies with complicated production processes and by-products. It is not easy to develop a generic platform process like monoclonal antibodies and needs to develop specific purification processes. Mismatching products and aggregates are typical by-products in IgG-like bispecific antibody production, which have been a nodus of purification. This review briefly overviews the structures of IgG-like bispecific antibody molecules and their corresponding purification processes, and focuses on the removal strategies of asymmetric IgG-like bispecific antibodies homodimers, 1/2 half antibody or 3/4 antibody fragments lacking light chain, and aggregates of symmetric IgG-like bispecific antibodies, in order to provide some references and new ideas for the development of purification processes for IgG-like bispecific antibodies.

, authors=Baoqing FAN, Zhenyu WANG*, authorsList=Baoqing FAN, Zhenyu WANG, authorCompany=null, correspAuthors=Zhenyu WANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330184289326575915, articleId=1330184288881979689, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=类IgG双特异性抗体纯化工艺研究进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

类IgG双特异性抗体是人工构建的功能性抗体,其生产工艺烦琐、副产物复杂多样,很难构建像单抗类药物一样的通用型平台工艺,常需建立针对性的分离纯化工艺。错配产物和聚集体是类IgG双特异性抗体生产中常见的副产品,是分离纯化的难点。该文简要概述了应用较广泛的类IgG双特异性抗体的分子结构及其对应的纯化工艺,重点阐述了不对称型类IgG双特异性抗体同源二聚体、1/2半抗或者缺失轻链的3/4不完整的抗体片段,以及对称型类IgG双特异性抗体聚集体的去除策略,以期为类IgG双特异性抗体的分离纯化工艺开发提供文献参考和新思路。

, authors=范宝庆, 王振玉*, authorsList=范宝庆, 王振玉, authorCompany=null, correspAuthors=王振玉, authorNote=

范宝庆(1982—),男,高级工程师,从事大分子生物药的下游分离纯化研究。

, correspAuthorsNote=
王振玉(1986—),男,博士,从事大分子生物药研发与CMC。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=jdt3FI+v2/08lLxqTMxRVw==, magXml=hCynJp0iIeHWRJxy8RoM/w==, pdfUrl=null, pdf=gfSNwtghPpWivsMTFstFwA==, pdfFileSize=2787470, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=4WKzdKJN4oDo9jJbZe8xhg==, mapNumber=null, fund=null)}, authors=[Author(id=1330184289603399986, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184289678897460, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, authorId=1330184289603399986, language=EN, stringName=Baoqing FAN, firstName=Baoqing, middleName=null, lastName=FAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jecho(Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184289737617717, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, authorId=1330184289603399986, language=CN, stringName=范宝庆, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=杰科(天津)生物医药有限公司,天津 300480, bio={"content":"

范宝庆(1982—),男,高级工程师,从事大分子生物药的下游分离纯化研究。

"}, bioImg=null, bioContent=

范宝庆(1982—),男,高级工程师,从事大分子生物药的下游分离纯化研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184289519513902, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, xref=null, ext=[AuthorCompanyExt(id=1330184289527902511, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, companyId=1330184289519513902, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jecho(Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480), AuthorCompanyExt(id=1330184289536291120, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, companyId=1330184289519513902, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=杰科(天津)生物医药有限公司,天津 300480)])]), Author(id=1330184289796337975, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhenyu.wang@jechobio.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330184289867641145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, authorId=1330184289796337975, language=EN, stringName=Zhenyu WANG, firstName=Zhenyu, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Jecho(Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184289926361402, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, authorId=1330184289796337975, language=CN, stringName=王振玉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=杰科(天津)生物医药有限公司,天津 300480, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184289519513902, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, xref=null, ext=[AuthorCompanyExt(id=1330184289527902511, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, companyId=1330184289519513902, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jecho(Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480), AuthorCompanyExt(id=1330184289536291120, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, companyId=1330184289519513902, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=杰科(天津)生物医药有限公司,天津 300480)])])], keywords=[Keyword(id=1330184290010247483, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, language=EN, orderNo=1, keyword=bispecific antibody), Keyword(id=1330184290068967740, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, language=EN, orderNo=2, keyword=IgG-like), Keyword(id=1330184290131882301, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, language=EN, orderNo=3, keyword=purification process), Keyword(id=1330184290198991166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, language=EN, orderNo=4, keyword=homodimer), Keyword(id=1330184290266100031, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, language=EN, orderNo=5, keyword=aggregate), Keyword(id=1330184290341597504, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, language=CN, orderNo=1, keyword=双特异性抗体), Keyword(id=1330184290400317761, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, language=CN, orderNo=2, keyword=类IgG), Keyword(id=1330184290467426626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, language=CN, orderNo=3, keyword=纯化工艺), Keyword(id=1330184290530341187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, language=CN, orderNo=4, keyword=同源二聚体), Keyword(id=1330184290614227268, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, language=CN, orderNo=5, keyword=聚集体)], refs=[Reference(id=1330184290714890565, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=吕明,王军志,沈倍奋.双特异性抗体结构与作用机制研究进展[J].中国新药杂志,2019,28(21):7., articleTitle=null, refAbstract=null), Reference(id=1330184290786193734, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=毛开云,李荣,李丹丹,等.全球双特异性抗体药物研发格局分析[J].中国生物工程杂志,2021,41(11):110-118., articleTitle=null, refAbstract=null), Reference(id=1330184290853302599, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=LABRIJN A F, JANMAAT M L, REICHERT J M, et al. Bispecific antibodies: a mechanistic review of the pipeline [J]. Nat Rev Drug Discov, 2019, 18(8): 585-608., articleTitle=null, refAbstract=null), Reference(id=1330184290941382984, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN S W, ZHANG W. Current trends and challenges in the downstream purification of bispecific antibodies [J]. Antib Ther, 2021, 4(2): 73-88., articleTitle=null, refAbstract=null), Reference(id=1330184291033657673, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Li Y F, WANG Y, SHEN P, et al. A roadmap for IgG-like bispecific antibody purification [M]// ALLAN MATTE. Approaches to the purification, analysis and characterization of antibody-based therapeutics. Amsterdam: Elsevier, 2020:167-179., articleTitle=null, refAbstract=null), Reference(id=1330184291104960842, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=GIESE G, WILLIAMS A, RODRIGUEZ M, et al. Bispecific antibody process development: assembly and purification of knob and hole bispecific antibodies [J]. Biotechnol Prog,2018, 34(2): 397-404., articleTitle=null, refAbstract=null), Reference(id=1330184291184652619, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=DENGL S, MAYER K, BOHRMANN F, et al. Format chain exchange(FORCE) for high-throughput generation of bispecific antibodies in combinatorial binder-format matrices[J]. Nat Commun, 2020, 11(1): 4974., articleTitle=null, refAbstract=null), Reference(id=1330184291251761484, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=IGAWA T, TSUNODA H. Antibody modification method for purifying bispecific antibody: EP, 2009101A4 [P]. 2009-10-21., articleTitle=null, refAbstract=null), Reference(id=1330184291323064653, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=GUO G L, HAN J Y, WANG Y, et al. A potential downstream platform approach for WuXiBody-based IgG-like bispecific antibodies [J]. Protein Expr Purif, 2020,173: 105647., articleTitle=null, refAbstract=null), Reference(id=1330184291390173518, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=WAN Y, WANG Y M, ZHANG T, et al. Application of pH-salt dual gradient elution in purifying a WuXiBody-based bispecific antibody by MMC ImpRes mixed-mode chromatography [J]. Protein Expr Purif, 2021, 181:105822., articleTitle=null, refAbstract=null), Reference(id=1330184292996591953, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=TUSTIAN A D, ENDICOTT C, ADAMS B, et al. Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity [J]. MABs, 2016, 8(4): 828-838., articleTitle=null, refAbstract=null), Reference(id=1330184293097255250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU P F, ZHANG J, YANG Y X. Bispecific antibody:US, 9079965B2 [P]. 2015-07-14., articleTitle=null, refAbstract=null), Reference(id=1330184293168558419, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU P F, ZHANG J, YANG Y X. Bispecific antibody:US, 9562110B2 [P]. 2017-02-07., articleTitle=null, refAbstract=null), Reference(id=1330184293248250196, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU P F, WANG T, FANG L J, et al. Construction and application of bispecific antibody EpCAM×CD3: US,9777073B2 [P]. 2017-10-03., articleTitle=null, refAbstract=null), Reference(id=1330184293319553365, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=NICOLAS F, JEAN-FRANCOIS D, KEITH W, et al. Methods of purifying bispecific antibodies: US,20200181287A1 [P]. 2020-06-11., articleTitle=null, refAbstract=null), Reference(id=1330184293378273622, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=HAN L, CHEN J S, DING K, et al. Efficient generation of bispecific IgG antibodies by split intein mediated protein trans-splicing system [J]. Sci Rep, 2017, 7(1): 8360., articleTitle=null, refAbstract=null), Reference(id=1330184293445382487, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=ZONG H F, HAN L, CHEN J, et al. Kinetics study of the natural split Npu DnaE intein in the generation of bispecific IgG antibodies [J]. Appl Microbiol Biotechnol, 2022,106(1): 161-171., articleTitle=null, refAbstract=null), Reference(id=1330184293562823000, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG L, QIAO Y, ZONG H F, et al. IgG-like bispecific antibody CD3×EpCAM generated by split intein against colorectal cancer [J]. Front Pharmacol, 2022, 13:803059., articleTitle=null, refAbstract=null), Reference(id=1330184293629931865, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU Y X, ZONG H F, HAN L, et al. A novel bispecific antibody targeting CD3 and prolactin receptor(PRLR) against PRLR-expression breast cancer [J]. J Exp Clin Cancer Res, 2020, 39(1): 87., articleTitle=null, refAbstract=null), Reference(id=1330184293692846426, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=SUN R, ZHOU Y X, HAN L, et al. A rational designed novel bispecific antibody for the treatment of GBM [J]. Biomedicines, 2021, 9(6): 640., articleTitle=null, refAbstract=null), Reference(id=1330184293751566683, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=HAN L, ZONG H F, ZHOU Y X, et al. Naturally split intein Npu DnaE mediated rapid generation of bispecific IgG antibodies [J]. Methods, 2019, 154: 32-37., articleTitle=null, refAbstract=null), Reference(id=1330184293818675548, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=王磊.基于 “BAPTS” 技术构建双特异性抗体及其药效学研究[D].上海:上海交通大学硕士学位论文,2020., articleTitle=null, refAbstract=null), Reference(id=1330184293898367325, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=SCHUURMAN J, VINK T, DE WINKEL J V, et al. Bispecific antibodies and methods for production thereof:US, 20100105874A1 [P]. 2010-04-29., articleTitle=null, refAbstract=null), Reference(id=1330184293969670494, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=GRAMER M J, VAN DEN BREMER E T J, VAN KAMPEN M D, et al. Production of stable bispecific IgG1 by controlled Fab-arm exchange: scalability from bench to large-scale manufacturing by application of standard approaches[J]. Mabs, 2013, 5(6): 962-973., articleTitle=null, refAbstract=null), Reference(id=1330184294036779359, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=黎晓维,刘慧芳,王海彬,等.双特异性抗体的结构设计及其装配工艺研究进展[J].中国新药杂志,2014,23(20):2430-2436., articleTitle=null, refAbstract=null), Reference(id=1330184294112276832, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=STEINHARDT J, WU Y L, FLEMING R, et al. Fab-arm exchange combined with selective protein A purification results in a platform for rapid preparation of monovalent bispecific antibodies directly from culture media [J]. Pharmaceutics, 2019, 12(1): 3., articleTitle=null, refAbstract=null), Reference(id=1330184294179385697, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=LI Y F. Immunoglobulin-binding protein-based affinity chromatography in bispecific antibody purification: functions beyond product capture [J]. Protein Expr Purif, 2021, 188:105976., articleTitle=null, refAbstract=null), Reference(id=1330184294259077474, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN X, WANG Y, LI Y. Removing half antibody byproduct by protein A chromatography during the purification of a bispecific antibody [J]. Protein Expr Purif,2020, 172: 105635., articleTitle=null, refAbstract=null), Reference(id=1330184294351352163, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=GAO D, WANG L L, LIN D Q, et al. Evaluating antibody monomer separation from associated aggregates using mixed-mode chromatography [J]. J Chromatogr A, 2013, 1294:70-75., articleTitle=null, refAbstract=null), Reference(id=1330184294418461028, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=LI Y F. A brief introduction of IgG-like bispecific antibody purification: methods for removing product-related impurities[J]. Protein Expr Purif, 2019, 155: 112-119., articleTitle=null, refAbstract=null), Reference(id=1330184294502347109, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=GAGNON P. Improved antibody aggregate removal by hydroxyapatite chromatography in the presence of polyethylene glycol [J]. Immunol Methods, 2008, 336(2):222-228., articleTitle=null, refAbstract=null), Reference(id=1330184294632370536, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG X D, CHEN T, LI Y F. A parallel demonstration of different resins’ antibody aggregate removing capability by a case study [J]. Protein Expr Purif, 2019, 153: 59-69., articleTitle=null, refAbstract=null), Reference(id=1330184294724645225, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=KLUTERS S, HAFNER M, HIRSCHHEYDT T V, et al. Solvent modulated linear pH gradient elution for the purification of conventional and bispecific antibodies:modeling and application [J]. J Chromatogr A, 2015, 1418:119-129., articleTitle=null, refAbstract=null), Reference(id=1330184294795948394, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHENG J, WALKER J A, GHOSE S. Recovery and purification processing for bispecific antibody production[J]. Am Pharm Rev, 2021, 24(2): 65-69., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330184289519513902, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, xref=null, ext=[AuthorCompanyExt(id=1330184289527902511, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, companyId=1330184289519513902, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jecho(Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480), AuthorCompanyExt(id=1330184289536291120, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, companyId=1330184289519513902, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=杰科(天津)生物医药有限公司,天津 300480)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.06.004, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.06.004, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.06.004, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.06.004, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1686326400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
类IgG双特异性抗体纯化工艺研究进展
范宝庆 , 王振玉 *
中国医药工业杂志 | 综述 2023,54(6): 859-866
收起
收藏切换
中国医药工业杂志 |综述 2023 , 54 (6) : 859 -866
类IgG双特异性抗体纯化工艺研究进展
全屏
[Author(id=1330184289603399986, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184289678897460, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, authorId=1330184289603399986, language=EN, stringName=Baoqing FAN, firstName=Baoqing, middleName=null, lastName=FAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jecho(Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184289737617717, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, authorId=1330184289603399986, language=CN, stringName=范宝庆, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=杰科(天津)生物医药有限公司,天津 300480, bio={"content":"

范宝庆(1982—),男,高级工程师,从事大分子生物药的下游分离纯化研究。

"}, bioImg=null, bioContent=

范宝庆(1982—),男,高级工程师,从事大分子生物药的下游分离纯化研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184289519513902, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, xref=null, ext=[AuthorCompanyExt(id=1330184289527902511, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, companyId=1330184289519513902, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jecho(Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480), AuthorCompanyExt(id=1330184289536291120, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, companyId=1330184289519513902, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=杰科(天津)生物医药有限公司,天津 300480)])]), Author(id=1330184289796337975, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhenyu.wang@jechobio.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330184289867641145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, authorId=1330184289796337975, language=EN, stringName=Zhenyu WANG, firstName=Zhenyu, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Jecho(Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184289926361402, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, authorId=1330184289796337975, language=CN, stringName=王振玉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=杰科(天津)生物医药有限公司,天津 300480, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184289519513902, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, xref=null, ext=[AuthorCompanyExt(id=1330184289527902511, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, companyId=1330184289519513902, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jecho(Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480), AuthorCompanyExt(id=1330184289536291120, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184288881979689, companyId=1330184289519513902, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=杰科(天津)生物医药有限公司,天津 300480)])])]
范宝庆, 王振玉*
作者信息
  • 杰科(天津)生物医药有限公司,天津 300480
通讯作者:
王振玉(1986—),男,博士,从事大分子生物药研发与CMC。E-mail:
作者简介:

范宝庆(1982—),男,高级工程师,从事大分子生物药的下游分离纯化研究。

Advances in Purification Process of IgG-like Bispecific Antibodies
Baoqing FAN, Zhenyu WANG*
Affiliations
  • Jecho(Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480
出版时间: 2023-06-10 doi: 10.16522/j.cnki.cjph.2023.06.004
文章导航
收藏切换

类IgG双特异性抗体是人工构建的功能性抗体,其生产工艺烦琐、副产物复杂多样,很难构建像单抗类药物一样的通用型平台工艺,常需建立针对性的分离纯化工艺。错配产物和聚集体是类IgG双特异性抗体生产中常见的副产品,是分离纯化的难点。该文简要概述了应用较广泛的类IgG双特异性抗体的分子结构及其对应的纯化工艺,重点阐述了不对称型类IgG双特异性抗体同源二聚体、1/2半抗或者缺失轻链的3/4不完整的抗体片段,以及对称型类IgG双特异性抗体聚集体的去除策略,以期为类IgG双特异性抗体的分离纯化工艺开发提供文献参考和新思路。

双特异性抗体  /  类IgG  /  纯化工艺  /  同源二聚体  /  聚集体

IgG-like bispecific antibodies are artificially constructed functional antibodies with complicated production processes and by-products. It is not easy to develop a generic platform process like monoclonal antibodies and needs to develop specific purification processes. Mismatching products and aggregates are typical by-products in IgG-like bispecific antibody production, which have been a nodus of purification. This review briefly overviews the structures of IgG-like bispecific antibody molecules and their corresponding purification processes, and focuses on the removal strategies of asymmetric IgG-like bispecific antibodies homodimers, 1/2 half antibody or 3/4 antibody fragments lacking light chain, and aggregates of symmetric IgG-like bispecific antibodies, in order to provide some references and new ideas for the development of purification processes for IgG-like bispecific antibodies.

bispecific antibody  /  IgG-like  /  purification process  /  homodimer  /  aggregate
范宝庆, 王振玉. 类IgG双特异性抗体纯化工艺研究进展. 中国医药工业杂志, 2023 , 54 (6) : 859 -866 . DOI: 10.16522/j.cnki.cjph.2023.06.004
Baoqing FAN, Zhenyu WANG. Advances in Purification Process of IgG-like Bispecific Antibodies[J]. Chinese Journal of Pharmaceuticals, 2023 , 54 (6) : 859 -866 . DOI: 10.16522/j.cnki.cjph.2023.06.004

参考文献 引证文献
排序方式:
[1]
吕明,王军志,沈倍奋.双特异性抗体结构与作用机制研究进展[J].中国新药杂志,2019,28(21):7.
[2]
毛开云,李荣,李丹丹,等.全球双特异性抗体药物研发格局分析[J].中国生物工程杂志,2021,41(11):110-118.
[3]
LABRIJN A F, JANMAAT M L, REICHERT J M, et al. Bispecific antibodies: a mechanistic review of the pipeline [J]. Nat Rev Drug Discov, 2019, 18(8): 585-608.
[4]
CHEN S W, ZHANG W. Current trends and challenges in the downstream purification of bispecific antibodies [J]. Antib Ther, 2021, 4(2): 73-88.
[5]
Li Y F, WANG Y, SHEN P, et al. A roadmap for IgG-like bispecific antibody purification [M]// ALLAN MATTE. Approaches to the purification, analysis and characterization of antibody-based therapeutics. Amsterdam: Elsevier, 2020:167-179.
[6]
GIESE G, WILLIAMS A, RODRIGUEZ M, et al. Bispecific antibody process development: assembly and purification of knob and hole bispecific antibodies [J]. Biotechnol Prog,2018, 34(2): 397-404.
[7]
DENGL S, MAYER K, BOHRMANN F, et al. Format chain exchange(FORCE) for high-throughput generation of bispecific antibodies in combinatorial binder-format matrices[J]. Nat Commun, 2020, 11(1): 4974.
[8]
IGAWA T, TSUNODA H. Antibody modification method for purifying bispecific antibody: EP, 2009101A4 [P]. 2009-10-21.
[9]
GUO G L, HAN J Y, WANG Y, et al. A potential downstream platform approach for WuXiBody-based IgG-like bispecific antibodies [J]. Protein Expr Purif, 2020,173: 105647.
[10]
WAN Y, WANG Y M, ZHANG T, et al. Application of pH-salt dual gradient elution in purifying a WuXiBody-based bispecific antibody by MMC ImpRes mixed-mode chromatography [J]. Protein Expr Purif, 2021, 181:105822.
[11]
TUSTIAN A D, ENDICOTT C, ADAMS B, et al. Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity [J]. MABs, 2016, 8(4): 828-838.
[12]
ZHOU P F, ZHANG J, YANG Y X. Bispecific antibody:US, 9079965B2 [P]. 2015-07-14.
[13]
ZHOU P F, ZHANG J, YANG Y X. Bispecific antibody:US, 9562110B2 [P]. 2017-02-07.
[14]
ZHOU P F, WANG T, FANG L J, et al. Construction and application of bispecific antibody EpCAM×CD3: US,9777073B2 [P]. 2017-10-03.
[15]
NICOLAS F, JEAN-FRANCOIS D, KEITH W, et al. Methods of purifying bispecific antibodies: US,20200181287A1 [P]. 2020-06-11.
[16]
HAN L, CHEN J S, DING K, et al. Efficient generation of bispecific IgG antibodies by split intein mediated protein trans-splicing system [J]. Sci Rep, 2017, 7(1): 8360.
[17]
ZONG H F, HAN L, CHEN J, et al. Kinetics study of the natural split Npu DnaE intein in the generation of bispecific IgG antibodies [J]. Appl Microbiol Biotechnol, 2022,106(1): 161-171.
[18]
WANG L, QIAO Y, ZONG H F, et al. IgG-like bispecific antibody CD3×EpCAM generated by split intein against colorectal cancer [J]. Front Pharmacol, 2022, 13:803059.
[19]
ZHOU Y X, ZONG H F, HAN L, et al. A novel bispecific antibody targeting CD3 and prolactin receptor(PRLR) against PRLR-expression breast cancer [J]. J Exp Clin Cancer Res, 2020, 39(1): 87.
[20]
SUN R, ZHOU Y X, HAN L, et al. A rational designed novel bispecific antibody for the treatment of GBM [J]. Biomedicines, 2021, 9(6): 640.
[21]
HAN L, ZONG H F, ZHOU Y X, et al. Naturally split intein Npu DnaE mediated rapid generation of bispecific IgG antibodies [J]. Methods, 2019, 154: 32-37.
[22]
王磊.基于 “BAPTS” 技术构建双特异性抗体及其药效学研究[D].上海:上海交通大学硕士学位论文,2020.
[23]
SCHUURMAN J, VINK T, DE WINKEL J V, et al. Bispecific antibodies and methods for production thereof:US, 20100105874A1 [P]. 2010-04-29.
[24]
GRAMER M J, VAN DEN BREMER E T J, VAN KAMPEN M D, et al. Production of stable bispecific IgG1 by controlled Fab-arm exchange: scalability from bench to large-scale manufacturing by application of standard approaches[J]. Mabs, 2013, 5(6): 962-973.
[25]
黎晓维,刘慧芳,王海彬,等.双特异性抗体的结构设计及其装配工艺研究进展[J].中国新药杂志,2014,23(20):2430-2436.
[26]
STEINHARDT J, WU Y L, FLEMING R, et al. Fab-arm exchange combined with selective protein A purification results in a platform for rapid preparation of monovalent bispecific antibodies directly from culture media [J]. Pharmaceutics, 2019, 12(1): 3.
[27]
LI Y F. Immunoglobulin-binding protein-based affinity chromatography in bispecific antibody purification: functions beyond product capture [J]. Protein Expr Purif, 2021, 188:105976.
[28]
CHEN X, WANG Y, LI Y. Removing half antibody byproduct by protein A chromatography during the purification of a bispecific antibody [J]. Protein Expr Purif,2020, 172: 105635.
[29]
GAO D, WANG L L, LIN D Q, et al. Evaluating antibody monomer separation from associated aggregates using mixed-mode chromatography [J]. J Chromatogr A, 2013, 1294:70-75.
[30]
LI Y F. A brief introduction of IgG-like bispecific antibody purification: methods for removing product-related impurities[J]. Protein Expr Purif, 2019, 155: 112-119.
[31]
GAGNON P. Improved antibody aggregate removal by hydroxyapatite chromatography in the presence of polyethylene glycol [J]. Immunol Methods, 2008, 336(2):222-228.
[32]
ZHANG X D, CHEN T, LI Y F. A parallel demonstration of different resins’ antibody aggregate removing capability by a case study [J]. Protein Expr Purif, 2019, 153: 59-69.
[33]
KLUTERS S, HAFNER M, HIRSCHHEYDT T V, et al. Solvent modulated linear pH gradient elution for the purification of conventional and bispecific antibodies:modeling and application [J]. J Chromatogr A, 2015, 1418:119-129.
[34]
ZHENG J, WALKER J A, GHOSE S. Recovery and purification processing for bispecific antibody production[J]. Am Pharm Rev, 2021, 24(2): 65-69.
2023年第54卷第6期
23
5
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2023.06.004
  • 接收时间:2022-11-11
  • 首发时间:2026-11-19
  • 出版时间:2023-06-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-11-11
基金
作者信息
    杰科(天津)生物医药有限公司,天津 300480

通讯作者:

王振玉(1986—),男,博士,从事大分子生物药研发与CMC。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.06.004
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏